Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04902144 · ClinicalTrials.gov registry record · NA

Clinical Outcomes for Offering Genetic Testing in a Tiered Approach

A NA study of Malignant Solid Neoplasm and Breast Carcinoma, sponsored by Fred Hutchinson Cancer Center.

Completed
Registry status
NA
Development phase
6
Enrollment target
1
Study location

NCT04902144 is a NA study of Malignant Solid Neoplasm and Breast Carcinoma that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 6 participants, below the 1,141-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04902144, a NA study of Malignant Solid Neoplasm and Breast Carcinoma, has completed, sponsored by Fred Hutchinson Cancer Center.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target
1
Study location

Study Summary

This clinical quality improvement study reviews and develops a clinical operations workflow to identify cancer patients who meet criteria for genetic counseling and testing. This study may improve utilization of genetic counseling and testing amongst community-based oncology providers caring for cancer patients in a rural and underserved area.

Interventions

  • OTHER Questionnaire Administration
  • BEHAVIORAL Behavioral Intervention
  • OTHER Electronic Health Record Review

Study Locations (1)

Washington

  • Olympic Medical Cancer Center - Sequim

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2020-08-03
Est. Completion 2021-12-31
Phase NA

Sponsor

Fred Hutchinson Cancer Center

483 total trials

What the Registry Record Tells You About NCT04902144

The ClinicalTrials.gov registry entry for NCT04902144 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,141-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (99% lower). The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.

NCT04902144 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT04902144 about?

NCT04902144 is a clinical study titled "Clinical Outcomes for Offering Genetic Testing in a Tiered Approach". This clinical quality improvement study reviews and develops a clinical operations workflow to identify cancer patients who meet criteria for genetic counseling and testing. This study may improve utilization of genetic counseling and testing amongst community-based oncology providers caring for can...

What is the current status of trial NCT04902144?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2020-08-03. Estimated completion is 2021-12-31.

What conditions does trial NCT04902144 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Breast Carcinoma, Prostate Carcinoma, Ovarian Carcinoma, Pancreatic Carcinoma.

What interventions are being tested in trial NCT04902144?

The interventions under investigation include: Questionnaire Administration (OTHER), Behavioral Intervention (BEHAVIORAL), Electronic Health Record Review (OTHER).

Who is sponsoring clinical trial NCT04902144?

This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04902144 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.